Mycometrics

Monmouth Junction, United States Founded: 2005 • Age: 21 yrs
Microbiology testing services for environmental and medical samples are provided.

About Mycometrics

Provider of microbiology testing services for environmental and medical samples. This includes testing for various fungi and bacteria using methods such as standard culture, microscopic examination, and real-time PCR. Services cover environmental testing, such as ERMI and HERTSMI tests, water microbiology testing, and Legionella testing, as well as medical testing, such as breast implant testing. They also offer related products, including nasal cleanse kits and rinse packets. The companys focus is on accurate and rapid results.

  • Headquarter Monmouth Junction, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mycometrics.com
Operational Areas
Key Metrics
  • Latest Funding Round
    $146.24K (USD), Grant

    May 2010

  • Investors

Funding Insights of Mycometrics

  • Total Rounds 1
  • Last Round Grant β€” $146,237
  • First Round $146,237

    (May 2010)

  • Investors Count 1

All 1 funding rounds of Mycometrics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2010$146,237Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Mycometrics

Mycometrics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for Mycometrics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Mycometrics

2 dated milestones of Mycometrics across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Mycometrics is founded.
  2. Funding First funding round of $146K.

Web traffic of Mycometrics

The website of Mycometrics (mycometrics.com) receives about 5.4K visits a month.

  • Monthly visits
    5.4K

    ▲ 4.1% vs previous month

Similar websites

Websites whose visitors overlap most with Mycometrics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
envirobiomics.com
envirobiomics.com
100%
–#1,284,827–
themoldguyinc.com
97%
6.4K#3,516,517View details
biomerieux-usa.com
biomerieux-usa.com
74%
–#8,600,566–
accugenix.com
72%
11.9K#1,543,581View details
nelabservices.com
72%
2.2K#6,929,724View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 12 similar websites and full traffic analytics for Mycometrics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 12 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to Mycometrics

10 companies that operate in the same segment as Mycometrics (Infectious Diseases), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Therapeutics for drug-resistant bacterial infections are developed.
2013Cambridge, Massachusetts, United StatesUSD 114.7 MUSD 59.62 M32
Clinical diagnostics and drug discovery for immune diseases are provided.
2009Seattle, Washington, United StatesUSD 419.15 MUSD 276.98 M619
Vaccines for infectious diseases are developed using cell-free protein synthesis.
2013Foster City, California, United StatesUSD 347 M–414
Portable PCR diagnostics for infectious diseases are developed.
2010San Jose, California, United StatesUSD 386.33 M––
Developing glucan synthase inhibitors for the treatment of fungal infections.
1999Jersey City, New Jersey, United StatesUSD 62.65 MUSD 20.6 M28
Sherlock Biosciences is focused on molecular diagnostics development.
2019Watertown, United StatesUSD 111 M–33
Provider of diagnostic solutions for systemic infections
2016San Francisco, California, United StatesUSD 191.47 M–54
Developer of novel protein-based therapeutics using machine learning and biological engineering
2018Somerville, Massachusetts, United StatesUSD 693 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Mycometrics

Mycometrics was founded in 2005 and raised its 1st funding round 5 years after it was founded.

Mycometrics is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.

Provider of microbiology testing services for environmental and medical samples. This includes testing for various fungi and bacteria using methods such as standard culture, microscopic examination, and real-time PCR. Services cover environmental testing, such as ERMI and HERTSMI tests, water microbiology testing, and Legionella testing, as well as medical testing, such as breast implant testing. They also offer related products, including nasal cleanse kits and rinse packets. The companys focus is on accurate and rapid results.

Mycometrics has 1 investor. Key investors include HHS.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available